ClinicalTrials.Veeva

Menu

Low Level Laser (LED) Use to Increase Dental Implant Stability and Post Operative Analgesia

Mount Sinai Hospital, Canada logo

Mount Sinai Hospital, Canada

Status

Unknown

Conditions

Implant
Analgesia

Treatments

Device: OsseoPulse device (Light emitting diode technology)

Study type

Interventional

Funder types

Other

Identifiers

NCT01097499
MSH-Biolux2010

Details and patient eligibility

About

Study hypothesis: Low level laser (LED) will reduce initial bone resorption and improve primary stability of dental implant. It will also reduces post operative pain compared to patient without treatment

Implant osseointegration depends on many factors including biocompatibility of implant materials, design, surface, surgical access, patient conditions, biomechanical status, and lack of primary stability.

Several in vivo and in vitro studies showed the healing effect of low level laser therapy (LLLT) on bone by decreasing the initial bone resorption postoperatively and increasing the primary stability of the implant. It has also shown to have an analgesic effect intraorally when used post intraoral surgical procedures. The exact mechanism is unclear despite the fact that many hypothesis has been proposed.

In our study, our goal is to present, in a randomized standardized clinical trial, the effect of LLLT on post operative implant stability assessed by resonance frequency analysis (RFA). We will assess the subjective measures of postoperative pain using visual analog scale (VAS).

Enrollment

60 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

    1. English speaking

Exclusion criteria

    1. Systemic factors: Diabetes, systemic immune disease, smoking (non-smoking is not absolute, but preferable.)
    1. Local factors: No immediate implants, No grafting to the site, No other implants at separate location in the mouth around the same treatment period.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

LED application
Active Comparator group
Description:
Patients in this group will be given the LED device and will be instructed on how and when to use it. They will receive LED treatment to the surgical site preoperatively by the surgeon for 20 minutes. Then, patients in this group will apply LED at home to the surgical site postoperatively at the day of surgery and for the following 9 postoperative days.
Treatment:
Device: OsseoPulse device (Light emitting diode technology)
No LED application
No Intervention group
Description:
These patients will receive conventional dental implant treatment without the application of the LED therapy.

Trial contacts and locations

1

Loading...

Central trial contact

Mahdi Ghuloom, DDS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems